Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Go back to Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 90.21 +1.73 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.48 | 52 Week High | $10.00 | |||
| Open | $90.30 | 52 Week Low | $3.22 | |||
| Day High | $90.30 | P/E | N/A | |||
| Day Low | $86.82 | EPS | $-0.46 | |||
| Volume | 772,002 | |||||
